Cargando…
A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
Non‐alcoholic fatty liver disease is becoming a major health burden, as prevalence increases and there are no approved treatment options. Thiazolidinediones target the nuclear receptor peroxisome proliferator‐activated receptor γ (PPARγ) and have been investigated in several clinical trials for thei...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850367/ https://www.ncbi.nlm.nih.gov/pubmed/30561132 http://dx.doi.org/10.1111/bcpt.13190 |